These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 26160168)

  • 1. [Use of neuromuscular blockers in Brazil].
    Locks Gde F; Cavalcanti IL; Duarte NM; Cunha RM; Almeida MC
    Rev Bras Anestesiol; 2015; 65(5):319-25. PubMed ID: 26160168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of neuromuscular blockers in Brazil.
    Locks Gde F; Cavalcanti IL; Duarte NM; da Cunha RM; de Almeida MC
    Braz J Anesthesiol; 2015; 65(5):319-25. PubMed ID: 26323727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuromuscular blockers in Brazil.].
    Almeida MC
    Rev Bras Anestesiol; 2004 Dec; 54(6):850-64. PubMed ID: 19471800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A survey of the current use of neuromuscular blocking drugs among the Middle Eastern anesthesiologists.
    Eldawlatly A; El-Tahan MR;
    Saudi J Anaesth; 2013 Apr; 7(2):146-50. PubMed ID: 23956713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery from neuromuscular block after an intubation dose of cisatracurium and rocuronium in lumbar disc surgery.
    Hans P; Welter P; Dewandre PY; Brichant JF; Bonhomme V
    Acta Anaesthesiol Belg; 2004; 55(2):129-33. PubMed ID: 15264506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of sugammadex after neostigmine incomplete reversal of rocuronium-induced neuromuscular blockade.
    de Menezes CC; Peceguini LA; Silva ED; Simões CM
    Rev Bras Anestesiol; 2012 Jul; 62(4):543-7. PubMed ID: 22793970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved neuromuscular blockade using a novel neuromuscular blockade advisory system: a randomized, controlled, clinical trial.
    Gilhuly TJ; Macleod BA; Dumont GA; Bouzane AM; Schwarz SK
    Anesth Analg; 2008 Nov; 107(5):1609-17. PubMed ID: 18931219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of postoperative residual neuromuscular blockade in the postanaesthesia care unit: an observational multicentre study in Portugal.
    Esteves S; Martins M; Barros F; Barros F; Canas M; Vitor P; Seabra M; Castro MM; Bastardo I
    Eur J Anaesthesiol; 2013 May; 30(5):243-9. PubMed ID: 23344123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [French survey of neuromuscular relaxant use in anaesthetic practice in adults].
    Duvaldestin P; Cunin P; Plaud B; Maison P
    Ann Fr Anesth Reanim; 2008 Jun; 27(6):483-9. PubMed ID: 18571891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
    Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
    Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of neuromuscular blocking and hemodynamic effects of rocuronium and cisatracurium under sevoflurane or total intravenous anesthesia.
    Amin AM; Mohammad MY; Ibrahim MF
    Middle East J Anaesthesiol; 2009 Feb; 20(1):39-51. PubMed ID: 19266825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromuscular block: Monitoring, reversal, and residual blockade in small animals.
    Martin-Flores M
    Vet Ophthalmol; 2023 May; ():. PubMed ID: 37248035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of neuromuscular blockade in children at the time of block reversal and the removal of the endotracheal tube.
    de Souza CM; Romero FE; Tardelli MA
    Rev Bras Anestesiol; 2011; 61(2):145-9, 150-5, 78-83. PubMed ID: 21474022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual neuromuscular block after rocuronium or cisatracurium.
    de Morais BS; de Castro CH; Teixeira VC; Pinto AS
    Rev Bras Anestesiol; 2005 Dec; 55(6):622-30. PubMed ID: 19468536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of profound cisatracurium and rocuronium block: the role of objective assessment of neuromuscular function.
    Kopman AF; Kopman DJ; Ng J; Zank LM
    J Clin Anesth; 2005 Feb; 17(1):30-5. PubMed ID: 15721727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knowledge of residual curarization: an Italian survey.
    Di Marco P; Della Rocca G; Iannuccelli F; Pompei L; Reale C; Pietropaoli P
    Acta Anaesthesiol Scand; 2010 Mar; 54(3):307-12. PubMed ID: 19839947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of profound neuromuscular block by sugammadex administered three minutes after rocuronium: a comparison with spontaneous recovery from succinylcholine.
    Lee C; Jahr JS; Candiotti KA; Warriner B; Zornow MH; Naguib M
    Anesthesiology; 2009 May; 110(5):1020-5. PubMed ID: 19387176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromuscular transmission: new concepts and agents.
    de Boer HD
    J Crit Care; 2009 Mar; 24(1):36-42. PubMed ID: 19272537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuromuscular Blocking Agents and Monitoring in China: A Cross-Sectional Survey of Current Management.
    Wu H; Lin Z; Zhou R; Huang S; Chen L; Su Y; Cheng L; Zhang H
    Front Med (Lausanne); 2022; 9():770105. PubMed ID: 35572965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and duration of residual paralysis at the end of surgery after multiple administrations of cisatracurium and rocuronium.
    Maybauer DM; Geldner G; Blobner M; Pühringer F; Hofmockel R; Rex C; Wulf HF; Eberhart L; Arndt C; Eikermann M
    Anaesthesia; 2007 Jan; 62(1):12-7. PubMed ID: 17156221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.